Werewolf Therapeutics to Present at the 2025 Leerink Partners Global Biopharma Conference
A live webcast link for the Leerink Partners Global Biopharma Conference fireside chat will be available at https://investors.werewolftx.com/news-and-events/events. An archived replay will be ...
AEON Biopharma, Inc. to Participate in the Leerink Global Healthcare Conference
AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351 (k) biosimilar pathway, today announced that ...
OnKure Therapeutics to Present at Upcoming Leerink and Stifel Investor Conferences
OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on the development of novel ...
enGene to Participate in the Leerink Partners Global Healthcare Conference
BOSTON & MONTREAL, March 04, 2025--enGene Holdings Inc. (Nasdaq: ENGN or "enGene" or the "Company"), a clinical-stage, ...
Leerink Partnrs Estimates Kura Oncology FY2026 Earnings
Equities research analysts at Leerink Partnrs issued their FY2026 EPS estimates for Kura Oncology in a note issued to investors on Wednesday, February 26th. Leerink Partnrs analyst J. Chang ...
Q1 Earnings Estimate for argenx Issued By Leerink Partnrs
Equities researchers at Leerink Partnrs issued their Q1 2025 EPS estimates for argenx in a research report issued to clients ...
Business Wire11h
908 Devices to Participate in Upcoming Investor Conferences
Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced ...
Investor's Business Daily on MSN16h
AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.
AbbVie inked a licensing deal Monday worth up to $2.23 billion for an amylin-targeting obesity treatment from Denmark-based ...
Joplin Globe17h
Savara Announces Participation in the Leerink Global Healthcare Conference
Savara Inc. (Nasdaq: SVRA ) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that members of its management team will attend the Leerink ...
TMCnet1d
Altimmune to Participate in the Leerink Global Healthcare Conference
Altimmune is a late clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual ...
FiercePharma14d
Leerink group goes beyond conventional metrics to evaluate cost-effectiveness of key therapies
Launched in October by Leerink Partners, CPE evaluates the long-term societal impact of healthcare innovations, aiming to go beyond typical cost-effectiveness models by assessing therapies not ...
manilatimes14d
I-Mab to Participate in Leerink Partners Global Healthcare Conference
today announced that members of I-Mab's management will participate in one-on-one meetings at the Leerink Partners Global Healthcare Conference in Miami, Florida on Tuesday and Wednesday, March 11-12, ...